Carboranyl oligonucleotides: 4. Synthesis and physicochemical studies of oligonucleotides containing 2′-O-(o-carboran-1-yl)methyl group

Antisense and Nucleic Acid Drug Development

Volumn 12, Issue 2, 2002, Pages 79-94

  Olejniczak, Agnieszka B ^a   Koziolkiewicz, Maria ^b   Lesnikowski, Zbigniew J ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2' O (2 CARBORAN 1 YL)METHYL DERIVATIVE; ANTISENSE OLIGONUCLEOTIDE; BORON DERIVATIVE; CARBORANYL OLIGONUCLEOTIDE; COMPLEMENTARY DNA; PHOSPHODIESTERASE I; RNA; SNAKE VENOM; TETRADECANUCLEOTIDE; UNCLASSIFIED DRUG; ANTISENSE OLIGODEOXYNUCLEOTIDE; EXONUCLEASE; PHOSPHODIESTERASE; SPLEEN EXONUCLEASE;

ARTICLE; CIRCULAR DICHROISM; DRUG STABILITY; DRUG SYNTHESIS; LIPOPHILICITY; MASS SPECTROMETRY; MELTING POINT; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SERUM; SOLID; ULTRAVIOLET SPECTROSCOPY; ANIMAL; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; CYTOMEGALOVIRUS; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; NEOPLASM; NEUTRON CAPTURE THERAPY; NUCLEOTIDE SEQUENCE; SYNTHESIS; VIRUS GENE;

CROTALUS; CROTALUS ATROX; INSERTION SEQUENCES; SERPENTES;

ANIMALS; BASE SEQUENCE; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CHEMISTRY, PHYSICAL; CYTOMEGALOVIRUS; DRUG STABILITY; EXONUCLEASES; GENES, VIRAL; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES;

EID: 0035989857     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729002760070821     Document Type: Article

References (56)

1. The recognition and cleavage of RNA in the antisense oligo-RNA hybrid duplex by RNase H
2. Solid phase synthesis of oligodeoxyrubonucleotides by the phosphite-triester method
3. Oligodeoxyribonucleotide synthesis
4. Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′-terminus and their interaction with DNA within mammalian cells
5. Processivity and kinetics of the reaction of exonuclease I from Escherichia coli with polydeoxyribonucleotides
6. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3′ exonuclease in plasma
7. Potent estrogen agonist based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters
8. Protein kinase modulators bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore
9. Carboranyl oligonucleotides. 2. Synthesis and physicochemical properties of dodecathymidylate containing 5-(o-carboran-1-yl)-2′-deoxyuridine
10. Impact of 3′-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism
11. Comparative study of polyribonucleotides in aqueous and glycol solutions
12. Comments on the reaction of amines with 1,2-dicarbaclovododecaborane
13. The preparation and characterization of the (3)-1,2- and (3)-1,7-dicarbadodecahydroundecaborate (-1) ions
14. Lipid membrane permeability of 2′-modified derivatives of phosphorothioate oligonucleotides
15. High cellular uptake of lipophilic oligonucleotide prodrugs
16. 2′-O-alkyl oligoribonucleotides as antisense probes
17. Different conformations of double-stranded nucleic acids in solution as revealed by circular dichroism
18. Solution-phase synthesis of boron-rich phosphates
19. Synthesis and hybridization properties of oligonucleotides containing 2′-O-modified ribonucleotides
20. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: Diastereoselectivity of plasma 3′-exonuclease
21. Hydrolysis: Other C-N bonds phosphate esters
22. Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA: RNA duplex
23. Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2′-deoxyuridine
24. Comparison of physicochemical and biological properties of (o-carboran-1-yl)methylphosphonate and methylphosphonate oligonucleotides
25. Carboranyl oligonucleotides. 1. Synthesis of thymidine (3′,5′)thymidine (o-carboran-1-yl)methylphosphonate
26. Boron neutron capture therapy of cancers: Nucleic bases, nucleosides, and oligonucleotides as potential boron carriers
27. Nucleic acids and nucleosides containing carboranes
28. Synthesis and physical properties of anti-HIV antisense oligonucleotides bearing terminal lipophilic groups
29. Carbohydrate modifications in antisense oligonucleotide therapy: New kids on the block
30. The chain termini of polynucleotides formed by limited enzymic fragmentation of wheat embryo ribosomal RNA. 2. Studies of a snake venom ribonuclease and pancreas ribonuclease
31. Boranophosphate nucleic acids - A versatile DNA backbone
32. The stepwise degradation of thymidine oligonucleotides by snake venom and spleen phosphodiesterases
33. Comparison of the levels of phosphodiesterase, endonuclease, and monophosphatase in several snake venoms
34. Carbohydrates: Synthesis and applications in antisense therapeutics: An overview
35. Carboranyl oligonucleotides for antisense technology and boron neutron capture therapy of cancers
36. Synthesis, hybridization properties and antiviral activity of lipid- oligodeoxynucleotide conjugates
37. Boron chemistry for NCT
38. Boron containing nucleic acids. 2. Synthesis of oligodeoxynucleoside boranophosphates
39. The chemical basis for DNA diagnostics using boronated DNA
40. Synthesis of 2′-O-alkyloligoribonucleotides
41. Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy
42. The pro-oligonucleotide approach: Solid phase synthesis and preliminary evaluation of model pro-dodecathymidylates
43. Modulators of tumor necrosis factor α production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore
44. Preparation and synthetic utility of some organotin derivatives of nucleosides
45. Utility of boron clusters for drug design. Hansh-Fujita hydrophobic parameters π of dicarbacloso-dodecaboranyl groups
46. The 3′-modified antisense oligos promote faster hydrolysis of the target RNA by Rnase H than the natural counterpart counter-part